Evidence map›Paper›PMID 36713386›Full record

ArticleFrontiers in immunology2022

Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India.

Dhanasekaran Sivakumaran, Synne Jenum, Aashish Srivastava, Vidar M Steen, Mario Vaz, Timothy Mark Doherty, Christian Ritz, Harleen M S Grewal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Dhanasekaran SivakumaranDepartment of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.
Synne JenumDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Aashish SrivastavaGenome Core Facility, Clinical Laboratory (K2), Haukeland University Hospital, University of Bergen, Bergen, Norway.
Vidar M SteenGenome Core Facility, Clinical Laboratory (K2), Haukeland University Hospital, University of Bergen, Bergen, Norway.
Mario VazDepartment of Physiology, St. John's Medical College and Division of Health and Humanities, St. John's Research Institute, Koramangala, Bangalore, India.
Timothy Mark DohertyGlaxoSmithKline Vaccines, Wavre, Belgium.
Christian RitzDepartment of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.
Harleen M S GrewalDepartment of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.
Haukeland University Hospital · NOGlaxoSmithKline (Belgium) · BEOslo University Hospital · NOUniversity of Bergen · NOUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large proportion of the global tuberculosis (TB) burden is asymptomatic and not detectable by symptom-based screening, driving the TB epidemic through continued

Indexed as

Mycobacterium tuberculosisTuberculosisTuberculosis, PulmonaryHumansIndiaProspective Studieshost-derived biological markersincipient TBRNA-seq - RNA sequencingsubclinical TBtuberculosis

Identifiers

PMID36713386
PMCPMC9876034
OpenAlexW4315641287

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.